Skip to main content
. 2023 Nov 2;4(12):100599. doi: 10.1016/j.jtocrr.2023.100599

Figure 2.

Figure 2

(A) TTF by decrease in CEA levels and (B) OS by decrease in CEA levels, both revealing improved survival among patients with CEA level decrease greater than 70% from baseline. CEA, carcinoembryonic antigen; OS, overall survival; TTF, time-to-treatment failure.